2026

Oct 20, 2026

Journal of Pharmacy & Pharmaceutical Sciences

128. Integrated computational screening and biochemical validation identify natural small molecules targeting Aβ aggregation and dissociation

Hyewon Lee 1, Vijay Kumar 1, Soo Jung Shin 1, Yunkwon Nam 1, Sinae Jang 1, Hyeon soo Kim, Minseok Lee, Gyu Yong Song, Eun-Kyung Lim *, Han-Jung Chae *, Minho Moon *

PubMed

Sep 24, 2026

ACS Sensors

127. Machine Learning-Assisted Multiplex Profiling of Plasma-Derived Exosomal miRNAs for Alzheimer's Disease Classification

Yeonwoo Jeong 1, Jinyoung Kim, Jina Lee, Seong Uk Son, Taejoon Kang, Juyeon Jung, Joseph Park, Minho Moon *, Eunjung Kim *, Eun-Kyung Lim *

PubMed

Aug 13, 2026

Frontiers in Pharmacology

126. Alismatis Rhizoma prevents AβO-induced neuronal cell death and synaptic loss in Alzheimer's disease models

Seungmin Lee 1, In Gyoung Ju, Minji Lee, Jin Hee Kim, Yujin Choi, Chanmi Baek, Chan Kim, Kyuho Moon, Minho Moon, Yong Jun Kim, Myung Sook Oh *

PubMed

Aug 12, 2026

Science Advances

125. Long-term amyloid aggregation kinetic assay and rapid amyloid clustering enabled by programmable microdroplet water extraction

Da Yeon Cheong 1, Seokbeom Roh 1, Jung Bae Seong 1, Sang Won Lee, Dain Kang, Taeha Lee, Jiyeon Cho, Seung Pil Pack, Minho Moon, Wonseok Lee, Kyung Rok Nam, Bo Hyun Kim, Jae Yong Choi, Jinyoung Won, Kyung Seob Lim, Chang-Yeop Jeon, Yangzhi Zhu, Yeongjeon Lee *, Gyudo Lee *, Insu Park *

PubMed

July 22, 2026

Aging and Disease

124. Targeting the Microbiota-Butyrate-BHB Axis As a Potential Metabolic Therapeutic Strategy for Alzheimer’s Disease

Vijay Kumar 1, Sinae Jang 1, Yebeen Choi 1, Sujin Kim, Yunkwon Nam, MyeongHeon You, Minho Moon *

PubMed

Jun 18, 2026

Food & Function

123. Fucoxanthin enhances AMPK/mTOR-dependent autophagic flux and attenuates ferroptosis in Alzheimer's disease models

Nayoung Lee 1, Kumju Youn, Minho Moon, Dong-Seok Lee, Dong Hyun Kim, Chi-Tang Ho, Mira Jun *

PubMed

Mar 25, 2026

Frontiers in Immunology

122. A selective agonist of the prostacyclin receptor alleviates microglial and astroglial neuroinflammatory responses through P38 and NLRP3

Hyun-ju Lee 1, Sora Kang 1, Yoo Joo Jeong 1, Tae-Mi Jung, Jeong-Woo Hwang, Ji-Yeong Jang, Chan-Hu Gu, Seokjun Oh, Jeong-Heon Song, Minho Moon *, Hyang-Sook Hoe *

PubMed

Mar 2, 2026

Pharmaceutics

121. 2,3,4-Trihydroxybenzophenone Disassembles Amyloid β
Aggregates and Ameliorates Synaptic Deficits

Eunbi Cho1, Kumju Youn, Huiyoung Kwon, Ho Jung Bae, Minho Moon, Mira Jun, Dong Hyun Kim*

PubMed

Jan 9, 2026

Neurochemistry international

120. Swertisin improves Alzheimer's disease-like pathology in 5XFAD male mice through regulation in plasmin activity

Somin Moon 1, Huiyoung Kwon 1, Eunbi Cho, Seungheon Lee, Se Jin Park,

Minho Moon, Jong Hoon Ryu, Dae Sik Jang, Ho Jung Bae *, Dong Hyun Kim *

PubMed

2026

128. Integrated computational screening and biochemical validation identify natural small molecules targeting Aβ aggregation and dissociation

127. Machine Learning-Assisted Multiplex Profiling of Plasma-Derived Exosomal miRNAs for Alzheimer's Disease Classification

126. Alismatis Rhizoma prevents AβO-induced neuronal cell death and synaptic loss in Alzheimer's disease models

125. Long-term amyloid aggregation kinetic assay and rapid amyloid clustering enabled by programmable microdroplet water extraction

124. Targeting the Microbiota-Butyrate-BHB Axis As a Potential Metabolic Therapeutic Strategy for Alzheimer’s Disease

123. Fucoxanthin enhances AMPK/mTOR-dependent autophagic flux and attenuates ferroptosis in Alzheimer's disease models

122. A selective agonist of the prostacyclin receptor alleviates microglial and astroglial neuroinflammatory responses through P38 and NLRP3

121. 2,3,4-Trihydroxybenzophenone Disassembles Amyloid β Aggregates and Ameliorates Synaptic Deficits

120. Swertisin improves Alzheimer's disease-like pathology in 5XFAD male mice through regulation in plasmin activity

121. 2,3,4-Trihydroxybenzophenone Disassembles Amyloid β
Aggregates and Ameliorates Synaptic Deficits